Our approach is built on creating a genuine partnership with you
As a cosmetic shortcut, repeated without monitoring, safety becomes uncertain
News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
If phosphate levels are below 2.5mg/dL, this confirms the diagnosis and may require phosphate supplementation under medical supervision
Start here What is L-carnitine and why does it matter
Even if you arent at risk for diabetes, this effect can contribute to a general sense of well-being, which is a crucial component in any weight loss journey